Literature DB >> 18078836

Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2.

Hiromasa Tanaka1, Shizuo G Kamita, Nicola M Wolf, Todd R Harris, Zhaoju Wu, Christophe Morisseau, Bruce D Hammock.   

Abstract

Soluble epoxide hydrolase (sEH) is a multifunctional protein encoded by the EPHX2 gene. The biological functions and enzyme kinetics of sEH have been extensively investigated, however, little is known about its transcriptional regulation and mechanisms of tissue specific expression. Here, a luciferase gene based reporter assay was used to identify the minimal promoter and cis regulatory elements of EPHX2. The minimal promoter was identified as a GC-rich region between nts -374 and +28 with respect to the putative transcriptional start site. A reporter plasmid carrying this minimal promoter showed higher or similar activities in comparison to a reporter plasmid carrying nts -5,974 to +28 of EPHX2 in 9 human cell lines that were tested. Sp1 binding sites that are involved in augmenting the minimal promoter activity of EPHX2 were identified by nested deletion analysis, site-specific mutation, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078836      PMCID: PMC2699939          DOI: 10.1016/j.bbagrm.2007.11.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  65 in total

1.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

2.  Isolation of a human prostate carcinoma cell line (DU 145).

Authors:  K R Stone; D D Mickey; H Wunderli; G H Mickey; D F Paulson
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

3.  Isolation of high-molecular-weight DNA from mammalian cells.

Authors:  M Gross-Bellard; P Oudet; P Chambon
Journal:  Eur J Biochem       Date:  1973-07-02

4.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.

Authors:  D P Aden; A Fogel; S Plotkin; I Damjanov; B B Knowles
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

5.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

6.  Vascular localization of soluble epoxide hydrolase in the human kidney.

Authors:  Zhigang Yu; Benjamin B Davis; Christophe Morisseau; Bruce D Hammock; Jean L Olson; Deanna L Kroetz; Robert H Weiss
Journal:  Am J Physiol Renal Physiol       Date:  2003-12-09

7.  Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.

Authors:  Xueying Zhao; Tatsuo Yamamoto; John W Newman; In-Hae Kim; Takaho Watanabe; Bruce D Hammock; Janet Stewart; Jennifer S Pollock; David M Pollock; John D Imig
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

8.  Lipid epoxide hydrolase in rat lung preparations.

Authors:  A Sevanian; R A Stein; J F Mead
Journal:  Biochim Biophys Acta       Date:  1980-08-07

9.  Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation.

Authors:  Michael P Hutchens; Takaaki Nakano; Jennifer Dunlap; Richard J Traystman; Patricia D Hurn; Nabil J Alkayed
Journal:  Resuscitation       Date:  2007-08-28       Impact factor: 5.262

10.  Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues.

Authors:  Ahmed E Enayetallah; Richard A French; Michael S Thibodeau; David F Grant
Journal:  J Histochem Cytochem       Date:  2004-04       Impact factor: 2.479

View more
  17 in total

Review 1.  EET signaling in cancer.

Authors:  Dipak Panigrahy; Emily R Greene; Ambra Pozzi; Dao Wen Wang; Darryl C Zeldin
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.

Authors:  William G Sanders; Christophe Morisseau; Bruce D Hammock; Alfred K Cheung; Christi M Terry
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

Review 3.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

Review 4.  Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health.

Authors:  Christophe Morisseau; Bruce D Hammock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

5.  Effect of Soluble Epoxide Hydrolase in Hyperoxic Acute Lung Injury in Mice.

Authors:  Ping-Song Li; Wei Tao; Liu-Qing Yang; Yu-Sheng Shu
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

6.  Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.

Authors:  Yang-Ming Yang; Dong Sun; Sharath Kandhi; Ghezal Froogh; Jian Zhuge; Weihua Huang; Bruce D Hammock; An Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

7.  Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.

Authors:  Donghong Zhang; Xina Xie; Yequn Chen; Bruce D Hammock; Wei Kong; Yi Zhu
Journal:  Circ Res       Date:  2012-02-21       Impact factor: 17.367

Review 8.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

9.  Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy.

Authors:  Ding Ai; Wei Pang; Nan Li; Ming Xu; Paul D Jones; Jun Yang; Youyi Zhang; Nipavan Chiamvimonvat; John Y-J Shyy; Bruce D Hammock; Yi Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-06       Impact factor: 11.205

10.  Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.

Authors:  Benjamin Keserü; Eduardo Barbosa-Sicard; Ralph T Schermuly; Hiromasa Tanaka; Bruce D Hammock; Norbert Weissmann; Beate Fisslthaler; Ingrid Fleming
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.